What is Simpson-Golabi-Behmel syndrome

TL;DR: Simpson-Golabi-Behmel syndrome (SGBS) is a rare X-linked genetic disorder characterized by prenatal and postnatal overgrowth, distinctive facial features, and an increased risk of specific tumors. It primarily affects males and is caused by mutations or deletions in the GPC3 gene, leading to disruptions in normal cell growth and development.

What is Simpson-Golabi-Behmel syndrome?

Simpson-Golabi-Behmel syndrome is a rare condition belonging to a group of disorders known as overgrowth syndromes. Individuals with Simpson-Golabi-Behmel syndrome often experience accelerated growth before and after birth, leading to a larger than average birth weight and stature. Beyond physical stature, the syndrome affects multiple organ systems, resulting in a wide spectrum of clinical presentations. Because the condition is primarily X-linked, it is significantly more common and often more severe in males, while females may exhibit milder or limited symptoms due to the nature of X-chromosome inactivation.

How does Simpson-Golabi-Behmel syndrome affect the body?

The clinical manifestations of Simpson-Golabi-Behmel syndrome are diverse, and not every individual will experience all symptoms. The condition frequently involves craniofacial, skeletal, and visceral abnormalities. Common clinical findings include:

• Distinctive facial features: A broad face, macrostomia (large mouth), macroglossia (enlarged tongue), and a wide, upturned nose.


• Skeletal involvement: Additional fingers or toes (polydactyly), fused fingers (syndactyly), and vertebral anomalies.


• Visceral findings: Enlarged internal organs (visceromegaly), such as the liver, spleen, or kidneys, and potential heart defects.


• Tumor predisposition: A well-documented increased risk of developing embryonic tumors, most notably Wilms tumor (a type of kidney cancer) and hepatoblastoma (liver cancer) during childhood.

What causes Simpson-Golabi-Behmel syndrome?

Simpson-Golabi-Behmel syndrome is caused by mutations or deletions in the GPC3 gene located on the X chromosome. This gene provides instructions for making a protein called glypican-3, which acts as a regulator of cell growth and division. When this protein is dysfunctional, the body loses a critical "brake" on cellular proliferation, leading to the characteristic overgrowth and structural anomalies associated with Simpson-Golabi-Behmel syndrome. Understanding this genetic mechanism is essential for clinical management and genetic counseling.

How common is Simpson-Golabi-Behmel syndrome?

As a rare disease, the exact prevalence of Simpson-Golabi-Behmel syndrome remains difficult to establish, though it is considered extremely rare. While fewer than 200 cases have been reported in medical literature, the true number is likely higher due to potential under-diagnosis. Currently, 26 individuals with Simpson-Golabi-Behmel syndrome have joined the DiseaseMaps.org community, providing a vital network for families seeking peer support and shared experiences regarding this rare condition.

What differentiates this condition from other overgrowth syndromes?

Simpson-Golabi-Behmel syndrome is often compared to Beckwith-Wiedemann syndrome (BWS) because both involve overgrowth and tumor risk. However, they are clinically and genetically distinct. While BWS is typically associated with imprinting defects on chromosome 11, Simpson-Golabi-Behmel syndrome is specifically linked to the GPC3 gene. The presence of specific facial features, such as a large mouth and tongue, combined with a clear X-linked inheritance pattern, helps clinicians distinguish Simpson-Golabi-Behmel syndrome from other similar genetic conditions.

Next steps

• Consult with a clinical geneticist to confirm the diagnosis through molecular genetic testing of the GPC3 gene.


• Establish a long-term tumor surveillance protocol with a pediatric oncologist, as early detection is critical for the management of associated cancer risks.


• Connect with the DiseaseMaps.org community to engage with other families navigating the challenges of Simpson-Golabi-Behmel syndrome.


• Coordinate care with a multidisciplinary medical team, including cardiologists, endocrinologists, and surgeons, to address specific organ system needs.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.

References

• NIH GARD: Simpson-Golabi-Behmel syndrome overview.


• Orphanet: Rare disease database entry for Simpson-Golabi-Behmel syndrome (ORPHA:3161).


• OMIM: Online Mendelian Inheritance in Man entry #312870 for Simpson-Golabi-Behmel syndrome.


• PubMed: Peer-reviewed clinical literature regarding GPC3 gene mutations and overgrowth syndromes.